Clinical Trials
3 trialsNCT00019344 2015-04-29
Flavopiridol in Treating Patients With Refractory Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00082784 2014-12-23
Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms
National Cancer Institute (NCI)
Phase 1 Completed
NCT00003039 2013-02-05
Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed